Ameriprise
RPTP

Ameriprise’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Ameriprise’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-125,860
Closed -$676K – 3961
2016
Q2 		$676K Buy
+125,860
New +$645K ﹤0.01% 3040
2014
Q4 		– Sell
-40
Closed – – 5474
2014
Q3 		$0 Sell
40
-10
-20% -$102 ﹤0.01% 6170
2014
Q2 		$1K Buy
+50
New +$455 ﹤0.01% 5515
2013
Q4 		– Sell
-127,181
Closed -$1.9M – 5936
2013
Q3 		$1.9M Sell
127,181
-60,243
-32% -$722K ﹤0.01% 2482
2013
Q2 		$1.75M Buy
+187,424
New +$1.27M ﹤0.01% 2425

Other funds holding RPTP

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Ameriprise's RPTP Position: Q3 2016 in Review

Ameriprise sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 125,860 shares — an estimated $676K sold.

Ameriprise first reported a position in RPTP in Q2 2013 and held it in 5 quarters. The position peaked at $1.9M in Q3 2013. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Ameriprise reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Ameriprise sold 125,860 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $676K.
  • Ameriprise first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Ameriprise's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.9M in Q3 2013.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Ameriprise's 13F filing for Q3 2016, filed 8 Nov 2016.